BACKGROUND: This study aims to investigate the gender differences in treatment strategies among non-ST-segment elevation myocardial infarction (NSTEMI) patients ≥80 years old in China. METHODS: A total of 190 consecutive NSTEMI patients ≥80 years old in Fuwai Hospital were included from 2014 to 2017. These patients were grouped by gender, and sub-grouped by conservative treatment or invasive treatment. The clinical characteristics, medical history, discharge drug used, and prognosis were collected and compared between these two treatment strategies. RESULTS: There were significant differences between these two treatment strategies in terms of GRACE grade, history of myocardial infarction (MI), after coronary artery bypass grafting (CABG), III grade, renal dysfunction, anemia, and use of diuretic (P<0.05). In addition, the age, creatinine and Killip class of female patients, and the death and good prognosis of male patients were found to be significantly different between these two treatment strategies (P<0.05). The multivariate logistic regression analysis revealed that the death of males was significantly associated with treatment strategies in the multivariable logistic regression analysis (P<0.05). In addition, the Kaplan-Meier survival analyses revealed that the survival rates of invasive strategy were significantly higher, when compared to that of conservative strategy in males (P=0.001) and females (P=0.015). CONCLUSIONS: There were gender differences in treatment strategies among NSTEMI patients ≥80 years old. The difference in treatment strategies in males was more pronounced than in females, in terms of long-term survival rate. 2019 Journal of Thoracic Disease. All rights reserved.
BACKGROUND: This study aims to investigate the gender differences in treatment strategies among non-ST-segment elevation myocardial infarction (NSTEMI) patients ≥80 years old in China. METHODS: A total of 190 consecutive NSTEMI patients ≥80 years old in Fuwai Hospital were included from 2014 to 2017. These patients were grouped by gender, and sub-grouped by conservative treatment or invasive treatment. The clinical characteristics, medical history, discharge drug used, and prognosis were collected and compared between these two treatment strategies. RESULTS: There were significant differences between these two treatment strategies in terms of GRACE grade, history of myocardial infarction (MI), after coronary artery bypass grafting (CABG), III grade, renal dysfunction, anemia, and use of diuretic (P<0.05). In addition, the age, creatinine and Killip class of female patients, and the death and good prognosis of male patients were found to be significantly different between these two treatment strategies (P<0.05). The multivariate logistic regression analysis revealed that the death of males was significantly associated with treatment strategies in the multivariable logistic regression analysis (P<0.05). In addition, the Kaplan-Meier survival analyses revealed that the survival rates of invasive strategy were significantly higher, when compared to that of conservative strategy in males (P=0.001) and females (P=0.015). CONCLUSIONS: There were gender differences in treatment strategies among NSTEMI patients ≥80 years old. The difference in treatment strategies in males was more pronounced than in females, in terms of long-term survival rate. 2019 Journal of Thoracic Disease. All rights reserved.
Authors: Tanush Gupta; Dhaval Kolte; Sahil Khera; Nayan Agarwal; Pedro A Villablanca; Kashish Goel; Kavisha Patel; Wilbert S Aronow; Jose Wiley; Anna E Bortnick; Herbert D Aronow; J Dawn Abbott; Robert T Pyo; Julio A Panza; Mark A Menegus; Charanjit S Rihal; Gregg C Fonarow; Mario J Garcia; Deepak L Bhatt Journal: Circ Cardiovasc Interv Date: 2018-01 Impact factor: 6.546
Authors: Hani Jneid; Jeffrey L Anderson; R Scott Wright; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar Journal: J Am Coll Cardiol Date: 2012-07-16 Impact factor: 24.094
Authors: Carolyn S P Lam; Margaret McEntegart; Brian Claggett; Jiankang Liu; Hicham Skali; Eldrin Lewis; Lars Køber; Jean Rouleau; Eric Velazquez; Rob Califf; John J McMurray; Marc Pfeffer; Scott Solomon Journal: Eur J Heart Fail Date: 2015-02-06 Impact factor: 15.534
Authors: K P Champney; P D Frederick; H Bueno; S Parashar; J Foody; C N B Merz; J G Canto; J H Lichtman; V Vaccarino Journal: Heart Date: 2009-01-15 Impact factor: 5.994
Authors: Jacob A Udell; Maria Koh; Feng Qiu; Peter C Austin; Harindra C Wijeysundera; Akshay Bagai; Andrew T Yan; Shaun G Goodman; Jack V Tu; Dennis T Ko Journal: J Am Heart Assoc Date: 2017-01-20 Impact factor: 5.501
Authors: Dragana Radovanovic; Burkhardt Seifert; Marco Roffi; Philip Urban; Hans Rickli; Giovanni Pedrazzini; Paul Erne Journal: Open Heart Date: 2017-11-14